HOME >> MEDICINE >> NEWS
Implanted defibrillators cut heart patients death risk, some more than others

NEW ORLEANS -- Implanted devices that can shock a failing heart back into regular rhythm do an excellent job of keeping patients alive, two new University of Michigan studies find.

The research also suggests that doctors may be able to categorize their patients according to their individual risk factors, to determine who might get the largest benefit from the expensive devices, called implanted cardiac defibrillators, or ICDs. The studies also reinforce the importance of providing good follow-up care to all heart failure patients, whether or not they receive an implanted device.

With Medicare poised to start covering ICDs for many more patients than ever before, the new results come just in time to help doctors decide which patients might get the greatest benefit from the costly devices. More than half a million more people may qualify for ICDs, which cost around $20,000, under Medicare guidelines that will take effect soon.

The data were presented here today in two talks at the Scientific Sessions of the American Heart Association by a U-M Cardiovascular Center team that analyzed data from 7,000 veterans treated for heart trouble in Veterans Affairs hospitals between 1995 and 1999. All had congestive heart failure, heart muscle damage caused by clogged blood vessels, and a heart rhythm irregularity called ventricular arrhythmia. Of the 7,000 patients, 1,442 had received an ICD.

The researchers found that those who received an ICD were 60 percent less likely to die in the next year, and 48 percent less likely to die in three years, than those who did not receive an ICD. Most of this reduction in death risk was due to reduction in heart-related deaths. ICDs are specifically designed to prevent sudden cardiac death, in which the heart's electrical system goes haywire, causing it to stop beating.

But ICD recipients who had co-existing medical conditions, especially diabetes or kidney failure, were much more likely to
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
8-Nov-2004


Page: 1 2 3 4

Related medicine news :

1. Implanted devices detect high-risk heart failure patients
2. Implanted defibrillators not covered for half of patients who could benefit, study finds
3. Implanted stimulator for Parkinsons disease impairs cognitive function
4. Implanted defibrillators and anti-theft systems appear safe under normal circumstances
5. Implantable heart defibrillators
6. More doubts over value of defibrillators
7. One use every seven years makes automated external defibrillators a good buy
8. Benefit of public defibrillators is marginal
9. Implantable defibrillators cost-effective for preventing sudden death
10. Health and fitness facilities need defibrillators
11. New study in Nature demonstrates protection against cell death during heart attack

Post Your Comments:
(Date:4/19/2015)... April 19, 2015 The American Institute ... with PROSHRED Security (“PROSHRED”) to host its second annual, ... shred their personal documents in order to raise funds ... , The June 6th event is being held at ... 2pm local time. The time will vary at select ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 HealthPostures, LLC ... announces that it will exhibit it’s pioneering ergonomics products ... and the Iowa-Illinois Safety Council Professional Development Conference and ... the TaskMate EZ are used in volume by call ... , Built to clamp to a desk, the ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog post explaining ... Spring. , Spring can be a great season ... sure they compare the newest policies before deciding on ... about Spring car insurance offers by reading the newly ... becoming more and more popular. Many insurance brokerage websites ...
(Date:4/18/2015)... 18, 2015 Insuranceautoquote.info has released a ... auto insurance quotes . , Clients can review ... website. The online environment provides important advantages for clients ... , Drivers who do not have coverage for their ... any season, day or hour. Many agencies offer important ...
(Date:4/18/2015)... the past few weeks, TheBeautyPlace.com has been undergoing maintenance ... run maintenance on our shipping facilities to update software ... Director. "It disrupted our regular shipping schedule but we ... track after having completed the maintenance." , Now, TheBeautyPlace.com ... has not allowed some calls to come in through ...
Breaking Medicine News(10 mins):Health News:2015 Annual Nationwide "Shred Cancer" Shredding Event 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:TheBeautyPlace.com Temporary Number Available 2
(Date:4/16/2015)... SHENZHEN, China , April 16, 2015 /PRNewswire/ ... a leading developer, manufacturer, and marketer of medical ... with the Securities and Exchange Commission an Annual Report ... for the year ended December 31, 2014. An electronic ... is available on Mindray,s investor relations website at  ...
(Date:4/16/2015)... , April 16, 2015  Amgen (NASDAQ: ... first quarter financial results on Tuesday, April 21, 2015, ... announcement will be followed by a conference call with ... the call from Amgen will be Robert A. ... members of Amgen,s senior management team. Live ...
(Date:4/16/2015)... Colo. , April 16, 2015  Rosewind ... completed a reverse merger with a newly formed ... an initial focus on addressing urological disorders. The ... Aytu BioScience Inc., has commenced operations and incorporates ... Luoxis Diagnostics.  The Company,s strategy is to build ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3
Cached News: